<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">mp4CLSrJfxZ98M5vqc3r3gN</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2013000100008</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(13)10000100008</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2012005000112</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigo Original</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Toler&#226;ncia ao esfor&#231;o em ratos com estenose a&#243;rtica e disfun&#231;&#227;o ventricular diast&#243;lica e/ou sist&#243;lica</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Mendes</surname>
            <given-names>Olga Castro</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sugizaki</surname>
            <given-names>Mario Mateus</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Campos</surname>
            <given-names>Dijon Salom&#233;</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Damatto</surname>
            <given-names>Ricardo Luiz</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Leopoldo</surname>
            <given-names>Andr&#233; Soares</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff04"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lima-Leopoldo</surname>
            <given-names>Ana Paula</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff04"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Baldissera</surname>
            <given-names>Vilmar</given-names>
          </name>
          <xref ref-type="aff" rid="aff05"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Padovani</surname>
            <given-names>Carlos Roberto</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Okoshi</surname>
            <given-names>Katashi</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cicogna</surname>
            <given-names>Antonio Carlos</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="city">Botucatu</named-content>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Estadual Paulista</institution>
        <institution content-type="orgdiv1">Faculdade de Medicina </institution>
        <institution content-type="orgdiv2">IDepartamento de Cl&#237;nica M&#233;dica</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff02">
        <addr-line>
          <named-content content-type="city">Bauru</named-content>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Faculdades Integradas de Bauru</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff05">
        <addr-line>
          <named-content content-type="city">S&#227;o Carlos</named-content>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Federal de S&#227;o Carlos</institution>
        <institution content-type="orgdiv1">Laborat&#243;rio de Fisiologia do Exerc&#237;cio </institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff04">
        <addr-line>
          <named-content content-type="city">Vit&#243;ria</named-content>
          <named-content content-type="state">Esp&#237;rito Santo</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Federal do Esp&#237;rito Santo</institution>
        <institution content-type="orgdiv1">Centro de Educa&#231;&#227;o F&#237;sica e Desportos </institution>
        <institution content-type="orgdiv2">Departamento de Desportos</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff03">
        <addr-line>
          <named-content content-type="city">Sinop</named-content>
          <named-content content-type="state">Mato Grosso</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Federal de Mato Grosso</institution>
        <institution content-type="orgdiv1">Instituto de Ci&#234;ncias da Sa&#250;de </institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>01</month>
        <year>2013</year>
      </pub-date>
      <volume>100</volume>
      <issue>1</issue>
      <fpage>44</fpage>
      <lpage>51</lpage>
      <history>
        <date date-type="received">
          <day>25</day>
          <month>04</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>31</day>
          <month>07</month>
          <year>2012</year>
        </date>
        <date date-type="rev-recd">
          <day>04</day>
          <month>07</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTO: A Toler&#226;ncia ao Esfor&#231;o F&#237;sico (TEF) &#233; uma medida de condicionamento cardiorrespirat&#243;rio. A capacidade aer&#243;bica &#233; reduzida na Insufici&#234;ncia Card&#237;aca (IC), embora n&#227;o haja dados dispon&#237;veis sobre esse par&#226;metro em animais com disfun&#231;&#227;o ventricular e sem sinais de IC. OBJETIVO: Avaliar a TEF em ratos com disfun&#231;&#227;o ventricular diast&#243;lica isolada ou associada com disfun&#231;&#227;o sist&#243;lica induzida pela Estenose da Aorta ascendente (EAo). M&#201;TODOS: Ratos Wistar machos jovens (20-30 dias de idade) foram divididos em Grupo Controle (GC, n = 11) e Grupo EAo (n = 12). Os animais foram avaliados em 6 e 18 semanas ap&#243;s a cirurgia para EAo. O teste ergom&#233;trico foi feito at&#233; a exaust&#227;o e foram avaliadas a velocidade da esteira e a concentra&#231;&#227;o de lactato [LAC] no limiar de lactato, velocidade da esteira e [LAC] na exaust&#227;o, e tempo total do teste. RESULTADOS: Dados ecocardiogr&#225;ficos revelaram remodela&#231;&#227;o do &#225;trio esquerdo e hipertrofia conc&#234;ntrica ventricular esquerda em 6 e 18 semanas. A fra&#231;&#227;o de encurtamento endoc&#225;rdico mostrou-se maior no grupo EAo do que no GC em 6 e 18 semanas. A fra&#231;&#227;o de encurtamento da parede m&#233;dia mostrou-se maior no grupo EAo do que no GC em 6 semanas. O &#237;ndice card&#237;aco mostrou-se semelhante no GC e no grupo EAo em 6 e 18 semanas, tendo diminu&#237;do entre 6-18 semanas em ambos os grupos. A raz&#227;o entre a onda E a onda A foi maior no GC do que no grupo EAo em ambos os per&#237;odos e n&#227;o se alterou em ambos os grupos entre a semana 6 e a semana 18. Os par&#226;metros do teste de esfor&#231;o na esteira foram semelhantes nos dois grupos tanto na semana 6 quanto na semana 18. CONCLUS&#195;O: Embora a EAo promova a disfun&#231;&#227;o diast&#243;lica isolada ou associada &#224; disfun&#231;&#227;o sist&#243;lica, em 6 ou 18 semanas, ela n&#227;o &#233; suficiente para alterar a toler&#226;ncia ao esfor&#231;o f&#237;sico.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>Ratos</kwd>
        <kwd>Exerc&#237;cio</kwd>
        <kwd>Estenose da Valva A&#243;rtica</kwd>
        <kwd>Disfun&#231;&#227;o Ventricular</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>30</day>
        <month>11</month>
        <year>2012</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>
      <bold>Toler&#226;ncia ao esfor&#231;o em ratos com estenose a&#243;rtica e disfun&#231;&#227;o ventricular diast&#243;lica e/ou sist&#243;lica</bold>
    </p>
    <p>
      <bold>Olga Castro Mendes<sup>I, II</sup>; Mario Mateus Sugizaki<sup>I, III</sup>; Dijon Salom&#233; Campos<sup>I</sup>; Ricardo Luiz Damatto<sup>I</sup>; Andr&#233; Soares Leopoldo<sup>I, IV</sup>; Ana Paula Lima-Leopoldo<sup>I, IV</sup>; Vilmar Baldissera<sup>V</sup>; Carlos Roberto Padovani<sup>I</sup>; Katashi Okoshi<sup>I</sup>; Antonio Carlos Cicogna<sup>I</sup></bold>
    </p>
    <p><sup>I</sup>Departamento de Cl&#237;nica M&#233;dica - Faculdade de Medicina - Universidade Estadual Paulista (UNESP) "J&#250;lio de Mesquita Filho", SP, Botucatu, Brasil </p>
    <p><sup>II</sup>Faculdades Integradas de Bauru, Bauru, SP, Brasil </p>
    <p><sup>III</sup>Instituto de Ci&#234;ncias da Sa&#250;de - Universidade Federal de Mato Grosso (UFMT), Sinop, MT, Brasil </p>
    <p><sup>IV</sup>Departamento de Desportos - Centro de Educa&#231;&#227;o F&#237;sica e Desportos - Universidade Federal do Esp&#237;rito Santo (UFES), Vit&#243;ria, ES, Brasil </p>
    <p><sup>V</sup>Laborat&#243;rio de Fisiologia do Exerc&#237;cio - Universidade Federal de S&#227;o Carlos (UFSCar), S&#227;o Carlos, SP, Brasil</p>
    <p>
      <xref ref-type="corresp" rid="end">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold>FUNDAMENTO:</bold> A Toler&#226;ncia ao Esfor&#231;o F&#237;sico (TEF) &#233; uma medida de condicionamento cardiorrespirat&#243;rio. A capacidade aer&#243;bica &#233; reduzida na Insufici&#234;ncia Card&#237;aca (IC), embora n&#227;o haja dados dispon&#237;veis sobre esse par&#226;metro em animais com disfun&#231;&#227;o ventricular e sem sinais de IC. </p>
    <p><bold>OBJETIVO:</bold> Avaliar a TEF em ratos com disfun&#231;&#227;o ventricular diast&#243;lica isolada ou associada com disfun&#231;&#227;o sist&#243;lica induzida pela Estenose da Aorta ascendente (EAo). </p>
    <p><bold>M&#201;TODOS:</bold> Ratos Wistar machos jovens (20-30 dias de idade) foram divididos em Grupo Controle (GC, n = 11) e Grupo EAo (n = 12). Os animais foram avaliados em 6 e 18 semanas ap&#243;s a cirurgia para EAo. O teste ergom&#233;trico foi feito at&#233; a exaust&#227;o e foram avaliadas a velocidade da esteira e a concentra&#231;&#227;o de lactato [LAC] no limiar de lactato, velocidade da esteira e [LAC] na exaust&#227;o, e tempo total do teste. </p>
    <p><bold>RESULTADOS:</bold> Dados ecocardiogr&#225;ficos revelaram remodela&#231;&#227;o do &#225;trio esquerdo e hipertrofia conc&#234;ntrica ventricular esquerda em 6 e 18 semanas. A fra&#231;&#227;o de encurtamento endoc&#225;rdico mostrou-se maior no grupo EAo do que no GC em 6 e 18 semanas. A fra&#231;&#227;o de encurtamento da parede m&#233;dia mostrou-se maior no grupo EAo do que no GC em 6 semanas. O &#237;ndice card&#237;aco mostrou-se semelhante no GC e no grupo EAo em 6 e 18 semanas, tendo diminu&#237;do entre 6-18 semanas em ambos os grupos. A raz&#227;o entre a onda E a onda A foi maior no GC do que no grupo EAo em ambos os per&#237;odos e n&#227;o se alterou em ambos os grupos entre a semana 6 e a semana 18. Os par&#226;metros do teste de esfor&#231;o na esteira foram semelhantes nos dois grupos tanto na semana 6 quanto na semana 18. </p>
    <p><bold>CONCLUS&#195;O:</bold> Embora a EAo promova a disfun&#231;&#227;o diast&#243;lica isolada ou associada &#224; disfun&#231;&#227;o sist&#243;lica, em 6 ou 18 semanas, ela n&#227;o &#233; suficiente para alterar a toler&#226;ncia ao esfor&#231;o f&#237;sico. (Arq Bras Cardiol. 2012; [online].ahead print, PP.0-0)</p>
    <p><bold>Palavras-Chave: </bold>Ratos; Exerc&#237;cio; Estenose da Valva A&#243;rtica; Disfun&#231;&#227;o Ventricular.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>O termo Remodela&#231;&#227;o Card&#237;aca (RC) tem sido amplamente utilizado e pode ser definido como uma altera&#231;&#227;o na express&#227;o gen&#233;tica resultando em altera&#231;&#245;es moleculares, celulares e intersticiais que se manifestam clinicamente como altera&#231;&#245;es no tamanho, forma e fun&#231;&#227;o do mioc&#225;rdio ap&#243;s a agress&#227;o<sup>1</sup>.</p>
    <p>A RC &#233; um importante mecanismo adaptativo para a carga hemodin&#226;mica cr&#244;nica que permite que o cora&#231;&#227;o mantenha suas fun&#231;&#245;es b&#225;sicas em resposta ao aumento de carga<sup>2</sup>, mas &#233; tamb&#233;m um fator de risco importante para a disfun&#231;&#227;o ventricular e insufici&#234;ncia card&#237;aca<sup>3</sup>.</p>
    <p>Diversos modelos experimentais t&#234;m sido propostos para investigar a RC induzida por sobrecarga de press&#227;o<sup>4-6</sup>. Mais recentemente, o modelo de estenose da aorta ascendente (EAo) tem sido usado para promover o desenvolvimento gradual da hipertrofia ventricular esquerda em ratos<sup>7-9</sup>. Nesse modelo, os animais desenvolvem remodela&#231;&#227;o card&#237;aca associada, no curto prazo, &#224; disfun&#231;&#227;o diast&#243;lica e melhora da fun&#231;&#227;o card&#237;aca seguida de menor desempenho sist&#243;lico e insufici&#234;ncia card&#237;aca<sup>10,11</sup>.</p>
    <p>O Teste de Esfor&#231;o F&#237;sico (TEF), um dos m&#233;todos mais utilizados para a avalia&#231;&#227;o n&#227;o invasiva da doen&#231;a cardiovascular, pode detectar anormalidades da fun&#231;&#227;o card&#237;aca n&#227;o observ&#225;veis em repouso<sup>12,13</sup>. A toler&#226;ncia ao TEF, uma medida normativa do condicionamento cardiorrespirat&#243;rio e capacidade aer&#243;bica, &#233; a capacidade de realizar atividades din&#226;micas durante o esfor&#231;o f&#237;sico. Essa capacidade &#233; comumente reduzida em pacientes e animais com Insufici&#234;ncia Card&#237;aca (IC)<sup>14,15</sup>. No entanto, informa&#231;&#245;es sobre pacientes e animais com disfun&#231;&#227;o ventricular e sem sinais de IC n&#227;o s&#227;o encontradas na literatura.</p>
    <p>O objetivo deste estudo foi testar a hip&#243;tese de que a toler&#226;ncia ao esfor&#231;o f&#237;sico &#233; prejudicada na presen&#231;a de disfun&#231;&#227;o ventricular diast&#243;lica isolada ou associada com disfun&#231;&#227;o sist&#243;lica e aus&#234;ncia de insufici&#234;ncia card&#237;aca induzida por estenose a&#243;rtica.</p>
    <p>
      <bold>M&#233;todos</bold>
    </p>
    <p>Todos os experimentos e procedimentos foram realizados de acordo com o Manual sobre cuidados e uso de animais de laborat&#243;rio publicado pelo Conselho Nacional de Pesquisa (1996), tendo sido aprovados pelo Comit&#234; de &#201;tica em Experimenta&#231;&#227;o Animal da Faculdade de Medicina de Botucatu - Universidade Estadual J&#250;lio Mesquita Filho (Unesp), em 19 de outubro de 2005 (n&#250;mero do protocolo 506/2005).</p>
    <p>
      <bold>Animais</bold>
    </p>
    <p>Vinte e tr&#234;s ratos machos jovens Wistar foram distribu&#237;dos aleatoriamente em dois grupos: controle (GC, n = 11) e estenose da aorta ascendente (EAo, n = 12). No grupo EAo, a estenose a&#243;rtica foi induzida por meio da coloca&#231;&#227;o de um anel de prata na aorta. O GC sofreu a mesma cirurgia, sem a coloca&#231;&#227;o de faixa. Todos os animais foram alojados em gaiolas individuais numa sala mantida a 23 &#176;C em um ciclo de luz-escurid&#227;o de 12:12-h e alimentados com ra&#231;&#227;o Purina&#174; padr&#227;o e &#225;gua <italic>ad libitum</italic>.</p>
    <p>
      <bold>Indu&#231;&#227;o da estenose da aorta ascendente </bold>
    </p>
    <p>A remodela&#231;&#227;o card&#237;aca foi induzida pela EAo de acordo com o m&#233;todo usado por diversos autores<sup>5,7,9</sup>. Os animais, pesando 70-90 g, com 20-30 dias de idade, foram submetidos &#224; toracotomia mediana sob anestesia com cloridrato de cetamina (60mg/kg e cloridrato de xilidina (10mg/kg) via intraperitoneal. A aorta ascendente foi dissecada e uma fita de prata com di&#226;metro interno de 0,6 mm foi colocada a aproximadamente 3 mm da raiz da aorta. Os animais do GC foram submetidos &#224; mesma cirurgia, mas sem a coloca&#231;&#227;o de fita.</p>
    <p>De acordo com estudos anteriores, os animais come&#231;am a desenvolver disfun&#231;&#227;o ventricular diast&#243;lica isolada ou associada com disfun&#231;&#227;o sist&#243;lica em 6 e 18 semanas ap&#243;s a cirurgia, respectivamente<sup>5,7,9</sup>. Assim, todos os animais foram avaliados nos seguintes per&#237;odos: 6 semanas (disfun&#231;&#227;o diast&#243;lica) e 18 semanas (disfun&#231;&#227;o diast&#243;lica associada sist&#243;lica).</p>
    <p>
      <bold>Avalia&#231;&#227;o ecocardiogr&#225;fica</bold>
    </p>
    <p>As fun&#231;&#245;es diast&#243;lica e sist&#243;lica do ventr&#237;culo esquerdo, bem como a estrutura do mioc&#225;rdio, foram avaliadas ecocardiograficamente de acordo com o m&#233;todo utilizado no nosso laborat&#243;rio<sup>7,16</sup>. Os animais foram anestesiados com cloridrato de cetamina (60mg/kg e cloridrato de xilidina (10mg/kg) via intraperitoneal (50 mg/kg) e cloridrato de xilidina (1 mg/kg) para o exame ecocardiogr&#225;fico em Modo M (Philips&#174;, modelo HDI 5000), equipado com um transdutor eletr&#244;nico de 12 MHz para medir o di&#226;metro do &#225;trio esquerdo (AE) e os seguintes par&#226;metros do ventr&#237;culo esquerdo: di&#226;metro diast&#243;lico e sist&#243;lico (DDVE e DSVE, respectivamente), espessura da parede posterior diast&#243;lica e sist&#243;lica (EDPVE e ESPVD, respectivamente), espessura do septo interventricular diast&#243;lico e sist&#243;lico (EDSIV e ESSIV) e massa do ventr&#237;culo esquerdo (massa do VE). O &#237;ndice de massa do ventr&#237;culo esquerdo (IMVE) foi determinado atrav&#233;s da normaliza&#231;&#227;o da massa do VE para o peso corporal (PC). A espessura relativa da parede do ventr&#237;culo esquerdo (ERPVE) foi estimada dividindo a EDPVE pelo DDVE.</p>
    <p>A fun&#231;&#227;o sist&#243;lica do VE foi determinada pela porcentagem de encurtamento endoc&#225;rdico (&#916;D endo) e da fra&#231;&#227;o de encurtamento da parede m&#233;dia (&#916;D mid) e &#237;ndice card&#237;aco (IC). A &#916;D mid foi calculada utilizando a f&#243;rmula ({[(DDVE + &#189; EDPP + &#189; EDSIV) - (DSVE + &#189; ESPP + &#189; ESSIV)]/(DDVE + &#189; EDPP + &#189; EDSIV)}). A &#916;D endo foi calculada pela f&#243;rmula ([(DDVE - DSVE)/DDVE x 100].</p>
    <p>A fun&#231;&#227;o diast&#243;lica foi avaliada por ondas E e A, a raz&#227;o entre as ondas E e A (E/A).</p>
    <p>
      <bold>Avalia&#231;&#227;o da toler&#226;ncia ao esfor&#231;o f&#237;sico</bold>
    </p>
    <p>
      <bold>Testes de esfor&#231;o f&#237;sico</bold>
    </p>
    <p>Os testes de esfor&#231;o f&#237;sico foram realizados utilizando-se uma esteira para ratos constru&#237;da pelo Centro Tecnol&#243;gico de Engenharia Cl&#237;nica - Universidade Estadual J&#250;lio Mesquita Filho (Unesp) de Botucatu, S&#227;o Paulo, Brasil. O protocolo utilizado para o teste incremental com multiest&#225;gios foi adaptado a partir do teste anteriormente descrito por Carvalho e cols.<sup>17</sup>. Cada animal foi testado individualmente. O teste consistiu de um aquecimento inicial de 5 minutos a 5m/min. Ap&#243;s 1 minuto de recupera&#231;&#227;o passiva, o animal foi submetido a um exerc&#237;cio incremental a uma velocidade de 6m/min seguido de aumentos de 3m/min a cada 3 minutos at&#233; a exaust&#227;o. A exaust&#227;o foi determinada quando o animal se recusava a executar, mesmo ap&#243;s estimula&#231;&#227;o sonora ou quando o animal se mostrava incapaz de coordenar passos. Depois de cada incremento de carga, o animal foi retirado manualmente da esteira por 1 min para a coleta de sangue<sup>18</sup>.</p>
    <p>
      <bold>Protocolo experimental </bold>
    </p>
    <p>A <xref ref-type="fig" rid="aop012fig1">figura 1</xref> mostra a representa&#231;&#227;o esquem&#225;tica de um protocolo de teste. Todos os ratos foram submetidos a um per&#237;odo de adapta&#231;&#227;o para se familiarizar com o protocolo de ensaio caminhando diariamente 5 m/min durante uma semana antes do teste. O teste de esfor&#231;o f&#237;sico foi realizado 6 e 18 semanas ap&#243;s a cirurgia nos grupos CG e EAo, isto &#233;, pela disfun&#231;&#227;o diast&#243;lica isolada ou associada &#224; disfun&#231;&#227;o sist&#243;lica, respectivamente.</p>
    <p content-type="asset">
      <fig id="aop012fig1">
        <graphic xlink:href="1678-4170-abc-100-01-0044-00112-gf01.jpg"/></fig>
    </p>
    <p>
      <bold>Par&#226;metros avaliados </bold>
    </p>
    <p>
      <bold>Velocidade da esteira (VLL, m/min) e concentra&#231;&#227;o de lactato ([LAC]<sub>LT</sub>, mmol/L) no limiar de lactato</bold>
    </p>
    <p>Para a avalia&#231;&#227;o da VLL e [LAC]<sub>LT</sub>, foi necess&#225;rio determinar o limiar de lactato (LL), definido como a intensidade do exerc&#237;cio em que a concentra&#231;&#227;o de lactato come&#231;a a aumentar substancialmente na corrente sangu&#237;nea durante o exerc&#237;cio incremental<sup>19</sup>. As amostras de sangue (25 uL) foram coletadas a partir da cauda dos animais em repouso e ap&#243;s cada aumento de carga. A coleta foi realizada com l&#226;minas de vidro para microscopia 25x75x1mm (<italic>Sigma Chemical Company&#174; -</italic> EUA, modelo<italic> Techware S 8902</italic>) e micropipetas digitais de (<italic>Nichiryo Co.</italic>&#174; - Jap&#227;o, modelo <italic>Nichipet NPX 200</italic>) com pontas descart&#225;veis que foram trocadas depois de cada coleta. O sangue coletado foi imediatamente armazenado em tubos Eppendorf de 1,5 mL com tampa contendo 50 uL de fluoreto 1%, anticoagulante e inibidor da enzima enolase para suprimir a atividade glicol&#237;tica. As amostras de sangue foram refrigeradas durante a coleta e, em seguida, mantidas em congelador at&#233; a sua utiliza&#231;&#227;o. A concentra&#231;&#227;o de lactato foi determinada pelo m&#233;todo eletroenzim&#225;tico usando um lact&#237;metro (<italic>Yellow Springs Instruments&#174;</italic>, 1500 <italic>Sport</italic> - EUA) de propriedade do Laborat&#243;rio de Fisiologia do Exerc&#237;cio do Departamento de Ci&#234;ncias Fisiol&#243;gicas - Universidade Federal de S&#227;o Carlos, S&#227;o Paulo, Brasil. O aparelho foi calibrado de acordo com as instru&#231;&#245;es do fabricante. As concentra&#231;&#245;es de lactato foram plotadas contra a velocidade de fase. O LL foi considerado como o ponto em que os n&#237;veis de lactato come&#231;aram a se elevar em fun&#231;&#227;o da velocidade, conforme detectado por inspe&#231;&#227;o visual. A velocidade e a concentra&#231;&#227;o de lactato encontradas nesse ponto foram consideradas como a velocidade e a concentra&#231;&#227;o de lactato no limiar de lactato (VLL e [LAC]<sub>LT</sub>, respectivamente). Os gr&#225;ficos foram analisados por dois investigadores experientes com concord&#226;ncia interobservador de 96%. Quando ocorria discord&#226;ncia sobre o LL, utilizou-se a m&#233;dia dos valores indicados por cada observador. A <xref ref-type="fig" rid="aop012fig2">figura 2</xref> apresenta o gr&#225;fico que representa os resultados de um dos animais.</p>
    <p content-type="asset">
      <fig id="aop012fig2">
        <graphic xlink:href="1678-4170-abc-100-01-0044-00112-gf02.jpg"/></fig>
    </p>
    <p>
      <bold>Velocidade da esteira (VEx, m/min) e concentra&#231;&#227;o de lactato ([LAC]<sub>EX</sub>, mmol/L) na exaust&#227;o </bold>
    </p>
    <p>Esses par&#226;metros foram determinados como descrito acima, por&#233;m at&#233; &#224; exaust&#227;o.</p>
    <p>
      <bold> Tempo total do teste (TTT, seg)</bold>
    </p>
    <p>O TTT foi a soma de todos os tempos de est&#225;gio at&#233; a exaust&#227;o. Os intervalos entre os est&#225;gios n&#227;o foram levados em considera&#231;&#227;o.</p>
    <p>
      <bold>Caracter&#237;sticas morfol&#243;gicas do corpo e do mioc&#225;rdio </bold>
    </p>
    <p>At&#233; o fim do experimento, os animais foram anestesiados com pentobarbital de s&#243;dio intraperitoneal (50 mg/kg) e decapitados. As seguintes vari&#225;veis foram avaliadas: peso corporal final (PC), peso do VE, peso do VD, peso atrial (A) (direito + esquerdo), VE/PC, A/PC. Os fragmentos do f&#237;gado (F&#205;GADO<sub>l/s</sub>) e pulm&#227;o (PULM&#195;O<sub>l/s</sub>) foram pesados antes e depois de terem sido postos em um forno a 60&#176;C por 48 h para se obter a raz&#227;o peso l&#237;quido/peso seco.</p>
    <p>
      <bold>An&#225;lise estat&#237;stica</bold>
    </p>
    <p>Os resultados s&#227;o relatados como medidas de posi&#231;&#227;o e variabilidade de acordo com a distribui&#231;&#227;o dos dados. Os par&#226;metros morfol&#243;gicos foram analisados utilizando o teste <italic>t</italic> de Student, quando a vari&#225;vel demonstrou ader&#234;ncia &#224; distribui&#231;&#227;o de probabilidade normal, e utilizando o teste de Mann-Whitney, quando da aus&#234;ncia dessa caracter&#237;stica. As compara&#231;&#245;es entre os grupos foram feitas utilizando ANOVA bifatorial de medidas repetidas com repeti&#231;&#227;o de um fator seguidas do procedimento de compara&#231;&#245;es m&#250;ltiplas de Bonferroni. Para par&#226;metros n&#227;o param&#233;tricos, foram utilizados o teste de Friedman e ANOVA por postos. O n&#237;vel de signific&#226;ncia para todos os testes foi definido a 5% (p &lt; 0,05). Os c&#225;lculos estat&#237;sticos foram realizados utilizando o programa<italic> SigmaStat </italic>3.5 para<italic> Windows </italic>(<italic>Copyright</italic><sup>&#169;</sup> 2006, <italic>Systat Software Inc</italic>.).</p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p>A <xref ref-type="table" rid="aop012tab1">tabela 1</xref> resume os dados morfol&#243;gicos. O peso corporal revelou-se similar no grupo controle (CG) e no grupo de estenose da aorta ascendente (EAo). VE/peso corporal, VD/peso corporal e A/peso corporal encontravam-se elevados no grupo EAo em compara&#231;&#227;o com o GC. N&#227;o houve diferen&#231;a nos fragmentos de F&#205;GADO<sub>l/s</sub> e PULM&#195;O<sub>l/s</sub>.</p>
    <p content-type="asset">
      <table-wrap id="aop012tab1">
        <graphic xlink:href="1678-4170-abc-100-01-0044-00112-gt01.jpg"/></table-wrap>
    </p>
    <p>A <xref ref-type="table" rid="aop012tab2">tabela 2</xref> mostra os dados ecocardiogr&#225;ficos seriais dos par&#226;metros estruturais e funcionais em 6 e 18 semanas no GC e no grupo EAo. O &#237;ndice de massa do ventr&#237;culo esquerdo diminuiu entre a semana 6 e a semana 18 no GC e permaneceu inalterado no grupo EAo; esse par&#226;metro se apresentou mais elevado no grupo EAo do que no GC nas semanas 6 e 18. A espessura relativa da parede do ventr&#237;culo esquerdo permaneceu inalterada no GC, mas se apresentou mais elevada na semana 6 e na semana 18 no grupo EAo; essa vari&#225;vel se apresentou mais elevada no grupo EAo do que no GC nas semanas 6 e 18. A raz&#227;o AE/PC diminuiu em ambos os grupos na semana 18 em compara&#231;&#227;o com a semana 6, tendo se apresentado mais elevada no grupo EAo do que no GC nos dois tempos avaliados. A fra&#231;&#227;o de encurtamento endoc&#225;rdico (&#916;D endo) e da parede m&#233;dia (&#916;D meso) n&#227;o se alterou com o tempo no GC, mas ambas diminu&#237;ram entre a semana 6 e 18 no grupo EAo; a &#916;D endo foi maior no grupo EAo do que no GC nas semanas 6 e 18; A &#916;D meso da parede m&#233;dia apresentou-se maior no grupo EAo do que no GC na semana 6 e similar em ambos os grupos na semana 18. O &#237;ndice card&#237;aco diminuiu em ambos os grupos entre a semana 6 e 18, tendo sido semelhante entre os dois grupos nos dois tempos avaliados. E/A mostrou-se semelhante nos dois grupos entre as semanas 6 e 18, no entanto, mostrou-se mais elevado no CG do que no grupo EAo nos dois momentos.</p>
    <p content-type="asset">
      <table-wrap id="aop012tab2">
        <graphic xlink:href="1678-4170-abc-100-01-0044-00112-gt02.jpg"/></table-wrap>
    </p>
    <p>A <xref ref-type="table" rid="aop012tab3">tabela 3</xref> mostra os resultados da avalia&#231;&#227;o da toler&#226;ncia ao esfor&#231;o f&#237;sico. Nenhum dos grupos apresentou diferen&#231;a significativa na velocidade na exaust&#227;o, tempo total do teste, velocidade no limiar de lactato, concentra&#231;&#245;es de lactato na VLL e VEx entre as semanas 6 e 18 . Esses par&#226;metros foram semelhantes entre o GC e EAo em ambos os momentos.</p>
    <p content-type="asset">
      <table-wrap id="aop012tab3">
        <graphic xlink:href="1678-4170-abc-100-01-0044-00112-gt03.jpg"/></table-wrap>
    </p>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>A estenose a&#243;rtica utilizada neste estudo promoveu precoce hipertrofia ventricular e do &#225;trio esquerdo, o que persistiu at&#233; ao final do experimento. Tal fato foi observado por meio da massa atrial e ventricular na an&#225;lise morfol&#243;gica e ecocardiogr&#225;fica. O aumento da espessura relativa da parede ventricular esquerda no grupo da estenose indica hipertrofia conc&#234;ntrica. Os dados est&#227;o de acordo com estudos anteriores que mostraram a remodela&#231;&#227;o card&#237;aca nesse modelo experimental<sup>5,9,11,20</sup>. A remodela&#231;&#227;o da c&#226;mara esquerda consiste em uma resposta adaptativa ao aumento da press&#227;o ventricular; o aumento da espessura da parede e diminui&#231;&#227;o do volume da cavidade normalizam o estresse parietal e, em consequ&#234;ncia, a fun&#231;&#227;o ventricular esquerda<sup>1,21</sup>. N&#227;o foram observados sinais cl&#237;nicos e morfol&#243;gicos de insufici&#234;ncia card&#237;aca, ou seja, taquipneia associada a edema, ascite, derrame pleuroperic&#225;rdico, trombose no AE ou hipertrofia do VD. O achado isolado de um aumento da raz&#227;o VD/PC n&#227;o indica que os ratos do grupo EAo desenvolveram insufici&#234;ncia card&#237;aca, o que foi confirmado pelo fato de que F&#205;GADO<sub>l/s</sub> e PULM&#195;O<sub>l/s</sub> mostraram-se semelhantes nos grupos controle e EAo.</p>
    <p>A fun&#231;&#227;o sist&#243;lica do VE, avaliada pela &#916;D endo e &#916;D meso, mostrou-se elevada no grupo EAo quando comparado com o GC na semana 6, e se deteriorou durante a remodela&#231;&#227;o no grupo EAo (<xref ref-type="table" rid="aop012tab2">tab. 2</xref>). A &#916;D endo observada na semana 6 mostrou-se semelhante &#224; relatada por Bregagnollo e cols.<sup>7,22</sup>, Ribeiro e cols.<sup>11</sup> e Litwin e cols.<sup>9</sup>, que encontraram melhora na fun&#231;&#227;o sist&#243;lica nesse momento. Al&#233;m disso, esses autores tamb&#233;m observaram piora ap&#243;s 18 ou 21 semanas. A melhora da fun&#231;&#227;o sist&#243;lica observada no grupo EAo, em compara&#231;&#227;o com o GC na semana 6 pode estar relacionada com o desenvolvimento de hipertrofia conc&#234;ntrica, normaliza&#231;&#227;o da tens&#227;o sist&#243;lica da parede, e manuten&#231;&#227;o do consumo de oxig&#234;nio do mioc&#225;rdio em sua gama fisiol&#243;gica<sup>9</sup>. A perda progressiva da fun&#231;&#227;o sist&#243;lica pode estar relacionada com a remodela&#231;&#227;o adversa da geometria ventricular, altera&#231;&#245;es na composi&#231;&#227;o do mioc&#225;rdio, insufici&#234;ncia progressiva de contratilidade ou com todos esses elementos combinados<sup>22-24</sup>.</p>
    <p>Diferentemente da fun&#231;&#227;o sist&#243;lica, o desempenho diast&#243;lico piorou precocemente no grupo EAo em compara&#231;&#227;o com o GC. Na semana 6, houve uma redu&#231;&#227;o na raz&#227;o E/A, que se manteve observ&#225;vel na semana 18. A raz&#227;o E/A no grupo EAo, que se apresentou menor do que no GC, sugere a presen&#231;a de disfun&#231;&#227;o diast&#243;lica. Nossos resultados diferem do autor<sup>9</sup> que n&#227;o observou mudan&#231;as na raz&#227;o E/A 6 semanas ap&#243;s a indu&#231;&#227;o de EAo em ratos e investigadores que encontraram aumento da raz&#227;o E/A nas semanas 12, 18 ou 21 ap&#243;s a indu&#231;&#227;o de EAo<sup>7,9,22</sup>. Resultados conflitantes podem ocorrer devido aos diferentes n&#237;veis de hipertrofia ventricular esquerda ou dificuldades t&#233;cnicas de obten&#231;&#227;o de imagens adequadas para a an&#225;lise do efeito Doppler; a alta frequ&#234;ncia card&#237;aca em ratos funde as ondas E e A, dificultando a medi&#231;&#227;o da fun&#231;&#227;o diast&#243;lica<sup>25</sup>. Apesar dos resultados inconsistentes encontrados na avalia&#231;&#227;o da fun&#231;&#227;o diast&#243;lica usando E/A de 6 semanas, um aumento no di&#226;metro do AE observado no presente estudo indica disfun&#231;&#227;o diast&#243;lica no VE, tendo em vista que uma melhora na fun&#231;&#227;o diast&#243;lica foi observada no grupo EAo em compara&#231;&#227;o com os controles. Durante a di&#225;stole ventricular, o AE est&#225; diretamente exposto a press&#245;es intraventriculares atrav&#233;s da valva mitral. Eventuais aumentos na press&#227;o diast&#243;lica ventricular aumentam a press&#227;o atrial e, assim, a remodela&#231;&#227;o da c&#226;mara. Estudos experimentais sobre a EAo t&#234;m associado a rigidez do mioc&#225;rdio com um aumento das fibras de col&#225;geno e altera&#231;&#245;es nas prote&#237;nas envolvidas na capta&#231;&#227;o de c&#225;lcio para o meio intracelular, particularmente a bomba de c&#225;lcio do ret&#237;culo sarcoplasm&#225;tico<sup>24</sup>. Assim, a depress&#227;o da fun&#231;&#227;o diast&#243;lica observada 6 e 18 semanas ap&#243;s a EAo pode estar relacionada com altera&#231;&#245;es nas propriedades el&#225;sticas e dist&#250;rbios no manuseio de c&#225;lcio.</p>
    <p>Embora os dados ecocardiogr&#225;ficos tenham mostrado altera&#231;&#245;es funcionais e estruturais nas semanas 6 e 18, o teste de toler&#226;ncia ao esfor&#231;o n&#227;o detectou altera&#231;&#227;o na capacidade funcional em ambos os grupos. De acordo com o nosso conhecimento, esta &#233; a primeira pesquisa que avaliou a toler&#226;ncia ao exerc&#237;cio f&#237;sico em ratos com estenose da aorta ascendente. O TTT foi o &#250;nico par&#226;metro que mostrou uma forte tend&#234;ncia de diminui&#231;&#227;o em animais com EAo (0,05 &lt; p &lt; 0,10). Respostas semelhantes ao esfor&#231;o podem se dar em virtude de: 1) protocolo inadequado; 2) Par&#226;metros insens&#237;veis para detectar mudan&#231;as na capacidade funcional; e 3) grau de disfun&#231;&#227;o ventricular. Com rela&#231;&#227;o ao primeiro item, o teste de esfor&#231;o f&#237;sico utilizado pode ser considerado adequado pelas seguintes raz&#245;es: i) m&#233;todos semelhantes t&#234;m sido utilizados em outros estudos experimentais<sup>17,26</sup>; ii) o teste permite submeter os animais a um programa de esfor&#231;o f&#237;sico individualizado; iii) o aumento gradual da carga interrompeu o padr&#227;o linear da curva de concentra&#231;&#227;o de lactato e permitiu determinar o n&#237;vel de LL; iiii) n&#227;o ocorreram &#243;bitos durante o teste ou imediatamente ap&#243;s o teste, o que indica que, embora se trata de um teste m&#225;ximo, ele pode ser usado no modelo experimental de EAo. Os par&#226;metros utilizados foram consideradas adequados porque: i) VLL e/ou VEx foram utilizados com sucesso em diversos trabalhos experimentais em ratos normais<sup>17,27,28</sup>, em ratos com estenose a&#243;rtica abdominal ou infarto do mioc&#225;rdio<sup>18,27</sup>; ii) O TTT tamb&#233;m tem sido usado para avaliar a capacidade funcional em animais infartados ou hipertensos<sup>26,29</sup>; em pacientes assintom&#225;ticos com EAo, foi considerado um bom preditor do aparecimento de sinais de insufici&#234;ncia card&#237;aca<sup>30</sup>; iii) [LAC]<sub>LT</sub> e [LAC]<sub>EX</sub> t&#234;m sido utilizados em estudos experimentais em seres humanos como marcador de intensidade de treino f&#237;sico<sup>28</sup>. Em rela&#231;&#227;o ao item 3, a literatura mostra que o teste de esfor&#231;o detectou redu&#231;&#227;o da capacidade funcional em animais com disfun&#231;&#227;o ventricular diast&#243;lica induzida por hipertens&#227;o arterial<sup>29</sup> ou, mais comumente, com insufici&#234;ncia card&#237;aca induzida por infarto do mioc&#225;rdio<sup>26</sup>. Al&#233;m disso, relata-se que o teste &#233; negativo em ratos com estenose da aorta abdominal e hipertrofia ventricular compensada<sup>27</sup>, e em um modelo de ratos com hiperadrenalinemia induzida por comprimidos de adrenalina.</p>
    <p>Neste estudo, n&#227;o foram observados sinais de insufici&#234;ncia card&#237;aca, muito embora o desempenho diast&#243;lico e sist&#243;lico estivesse prejudicado na EAo durante a remodela&#231;&#227;o. Uma vez que a literatura mostra que o teste de esfor&#231;o &#233; significativamente positivo em animais com insufici&#234;ncia card&#237;aca<sup>14,15</sup>, a aus&#234;ncia de altera&#231;&#245;es observada aqui pode estar relacionada ao grau de disfun&#231;&#227;o ventricular, provavelmente moderado. Os dados semelhantes de &#237;ndice card&#237;aco indicam perfus&#227;o do fluxo sangu&#237;neo perif&#233;rico equivalente entre os grupos. Outra explica&#231;&#227;o sobre a aus&#234;ncia de diferen&#231;a entre os grupos pode estar relacionada &#224; velocidade de exaust&#227;o dos ratos controle. O protocolo de teste de esfor&#231;o f&#237;sico mostrou baixos valores de velocidade de exaust&#227;o (15 m/min) e velocidade no limiar de lactato (9,0 m/min) em ratos controle.</p>
    <p>De acordo com a literatura, seriam esperados valores mais elevados desses par&#226;metros. Ferreira e cols.<sup>31</sup> observaram a velocidade na exaust&#227;o de 28 m/min e velocidade no limiar de lactato de 15 m/min em ratos que n&#227;o se submeteram a testes de esfor&#231;o f&#237;sico. Carvalho e cols.<sup>17</sup> observaram a velocidade na exaust&#227;o de 19,5 m/min e velocidade no limiar de lactato de 14,9 m/min em ratos que n&#227;o se submeteram a testes de esfor&#231;o f&#237;sico. Apesar dos dados controversos, a concentra&#231;&#227;o de lactato no momento da exaust&#227;o observada por n&#243;s foi semelhante a 18 m/min &#224; velocidade observada por Ferreira e cols.<sup>31</sup> e na velocidade de exaust&#227;o (19,5 m/min) observada por Carvalho e cols.<sup>17</sup>. Portanto, isso significa que os nossos ratos atingiram esfor&#231;o m&#225;ximo ou chegaram perto do esfor&#231;o m&#225;ximo durante o teste ergom&#233;trico.</p>
    <p>Os mecanismos respons&#225;veis pela redu&#231;&#227;o da capacidade de exerc&#237;cio ainda n&#227;o foram completamente elucidados. Dentre os poss&#237;veis fatores, podemos citar o fluxo insuficiente para o m&#250;sculo esquel&#233;tico secund&#225;rio &#224; disfun&#231;&#227;o sist&#243;lica e/ou diast&#243;lica e altera&#231;&#245;es no metabolismo da musculatura perif&#233;rica<sup>29</sup>. Uma vez que a resposta ao esfor&#231;o f&#237;sico permaneceu inalterada durante os testes incrementais, os fatores mencionados acima ou estavam ausentes ou de magnitude insuficiente nos ratos com EAo avaliados neste estudo.</p>
    <p>Algumas limita&#231;&#245;es sobre essa pesquisa devem ser citadas: 1) Teste de exerc&#237;cio f&#237;sico m&#225;ximo em ratos com hipertrofia ventricular podem ser perigosos devido ao risco de &#243;bito, portanto, nossos ratos podem ter realizado esfor&#231;o subm&#225;ximo durante o teste; 2) Falta de par&#226;metros funcionais que estimam a intensidade do exerc&#237;cio durante o teste f&#237;sico (ou seja, frequ&#234;ncia card&#237;aca, press&#227;o arterial, consumo de oxig&#234;nio); 3) Falta de dados da literatura sobre o tempo, corrida de velocidade, lactato em condi&#231;&#245;es experimentais similares.</p>
    <p>Em conclus&#227;o, n&#227;o houve altera&#231;&#245;es na toler&#226;ncia ao esfor&#231;o f&#237;sico na presen&#231;a de disfun&#231;&#227;o diast&#243;lica isolada ou associada &#224; disfun&#231;&#227;o sist&#243;lica. O grau de disfun&#231;&#227;o ventricular esquerda parece ser o principal determinante sobre os resultados do presente estudo. S&#227;o necess&#225;rios estudos adicionais, incluindo animais com disfun&#231;&#227;o ventricular maior ou insufici&#234;ncia card&#237;aca, bem como a an&#225;lise dos mecanismos que podem alterar a rela&#231;&#227;o de toler&#226;ncia ao esfor&#231;o/remodela&#231;&#227;o card&#237;aca.</p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>O presente estudo n&#227;o teve fontes de financiamento externas.</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>Este artigo &#233; parte de tese de mestrado de Olga de Castro Mendes da Silva pela Faculdade de Medicina da Universidade Estadual Paulista J&#250;lio de Mesquita Filho.</p>
    <p>
      <fn id="end" fn-type="corresp">
        <p>Correspond&#234;ncia:</p>
        <p> Mario Mateus Sugizaki &#149; </p>
        <p> Av. Alexandre Ferronato, 1200 - Setor Industrial - 78550-000 - Sinop, MT, Brasil </p>
        <p> E-mail: mario.</p>
        <p><email xlink:href="ufmt@gmail.com">ufmt@gmail.com</email>, </p>
        <p>
          <email xlink:href="mario.sugizaki@ig.com.br">mario.sugizaki@ig.com.br</email>
        </p>
      </fn>
    </p>
    <p>Recebido em 25/04/12, revisado recebido em 04/07/12, aceito em 31/07/12.</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling-concepts    and clinical implications: a consensus paper from an international forum on    cardiac remodeling. J Am Coll Cardiol. 2000;35(3):569-82.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>569</fpage>
          <lpage>82</lpage>
          <issue>3</issue>
          <volume>35</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Cohn</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Ferrari</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sharpe</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Berenji K, Drazner MH, Rothermel BA, Hill    JA. Does load-induced ventricular hypertrophy progress to systolic heart failure?    Am J Physiol Heart Circ Physiol. 2005;289(1):H8-H16.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Does load-induced ventricular hypertrophy progress to systolic heart failure</article-title>
          <source>Am J Physiol Heart Circ Physiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>H8</fpage>
          <lpage>H16</lpage>
          <issue>1</issue>
          <volume>289</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Berenji</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Drazner</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Rothermel</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Kaplan NM. Systemic hypertension: mechanisms    and diagnosis. In: Braunwald E, Zipes DP, Libby P. (eds.). Heart disease: a    textbook of cardiovascular medicine. 6<sup>th</sup> ed. Philadelphia: Saunders    Company; 2001. p. 941-1071.</mixed-citation>
        <element-citation publication-type="book">
          <source>Heart disease: a textbook of cardiovascular medicine</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>941</fpage>
          <lpage>1071</lpage>
          <person-group person-group-type="author">
            <name>
              <surname>Kaplan</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Braunwald</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Zipes</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Libby</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Okoshi MP, Matsubara LS, Franco M, Cicogna    AC, Matsubara BB. Myocyte necrosis is the basis for fibrosis in renovascular    hypertensive rats. Braz J Med Biol Res. 1997;30(9):1135-44.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Myocyte necrosis is the basis for fibrosis in renovascular hypertensive rats</article-title>
          <source>Braz J Med Biol Res</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>1135</fpage>
          <lpage>44</lpage>
          <issue>9</issue>
          <volume>30</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Okoshi</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Matsubara</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Franco</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cicogna</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Matsubara</surname>
              <given-names>BB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Weinberg EO, Schoen FJ, George D, Kagaya Y,    Douglas PS, Litwin SE, et al. Angiotensin-converting enzyme inhibition prolongs    survival and modifies the transition to heart failure with pressure overload    hypertrophy due ascending aortic stenosis. Circulation. 1994;90(3):1410-22.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure with pressure overload hypertrophy due ascending aortic stenosis</article-title>
          <source>Circulation</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>1410</fpage>
          <lpage>22</lpage>
          <issue>3</issue>
          <volume>90</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Weinberg</surname>
              <given-names>EO</given-names>
            </name>
            <name>
              <surname>Schoen</surname>
              <given-names>FJ</given-names>
            </name>
            <name>
              <surname>George</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kagaya</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Douglas</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Litwin</surname>
              <given-names>SE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Rossi MA, Peres LC. Effect of captopril on    the prevention and regression of myocardial cell hypertrophy and interstitial    fibrosis in pressure overload cardiac hypertrophy. Am Heart J. 1992;124(3):700-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effect of captopril on the prevention and regression of myocardial cell hypertrophy and interstitial fibrosis in pressure overload cardiac hypertrophy</article-title>
          <source>Am Heart J</source>
          <date>
            <year>1992</year>
          </date>
          <fpage>700</fpage>
          <lpage>9</lpage>
          <issue>3</issue>
          <volume>124</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rossi</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Peres</surname>
              <given-names>LC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Bregagnollo EA, Okoshi K, Bregagnollo IF,    Okoshi MP, Padovani CR, Cicogna AC. [Effects of the prolonged inhibition    of the angiotensin-converting enzyme on the morphological and functional characteristics    of left ventricular hypertrophy in rats with persistent pressure overload].    Arq Bras Cardiol. 2005;84(3):225-32.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>[Effects of the prolonged inhibition of the angiotensin-converting enzyme on the morphological and functional characteristics of left ventricular hypertrophy in rats with persistent pressure overload].</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>225</fpage>
          <lpage>32</lpage>
          <issue>3</issue>
          <volume>84</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bregagnollo</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Okoshi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Bregagnollo</surname>
              <given-names>IF</given-names>
            </name>
            <name>
              <surname>Okoshi</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Padovani</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Cicogna</surname>
              <given-names>AC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Schunkert H, Orzechowski HD, Bocker W, Meier    R, Riegger GA, Paul M. The cardiac endothelin system in established pressure    overload left ventricular hypertrophy. J Mol Med (Berl). 1999;77(8):623-30.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The cardiac endothelin system in established pressure overload left ventricular hypertrophy</article-title>
          <source>J Mol Med (Berl)</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>623</fpage>
          <lpage>30</lpage>
          <issue>8</issue>
          <volume>77</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Schunkert</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Orzechowski</surname>
              <given-names>HD</given-names>
            </name>
            <name>
              <surname>Bocker</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Meier</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Riegger</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Paul</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Litwin SE, Katz SE, Weinberg EO, Lorell BH,    Aurigemma GP, Douglas PS. Serial echocardiographic-Doppler assessment of left    ventricular geometry and function in rats with pressure overload hypertrophy    chronic angiotensin-converting enzyme inhibition attenuates the transition to    heart failure. Circulation. 1995;91(10):2642-54.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure overload hypertrophy chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure</article-title>
          <source>Circulation</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>2642</fpage>
          <lpage>54</lpage>
          <issue>10</issue>
          <volume>91</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Litwin</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Katz</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Weinberg</surname>
              <given-names>EO</given-names>
            </name>
            <name>
              <surname>Lorell</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>Aurigemma</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>Douglas</surname>
              <given-names>PS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Moreira VO, de Castro AV, Yaegaschi MY, Cicogna    AC, Okoshi MP, Pereira CA, et al. [Echocardiographic criteria for the definition    of ventricular dysfunction severity in aortic banded rats]. Arq Bras Cardiol.    2006;86(6):432-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>[Echocardiographic criteria for the definition of ventricular dysfunction severity in aortic banded rats].</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>432</fpage>
          <lpage>8</lpage>
          <issue>6</issue>
          <volume>86</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Moreira</surname>
              <given-names>VO</given-names>
            </name>
            <name>
              <surname>de Castro</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>Yaegaschi</surname>
              <given-names>MY</given-names>
            </name>
            <name>
              <surname>Cicogna</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Okoshi</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Ribeiro HB, Okoshi K, Cicogna AC, Bregagnollo    EA, Rodrigues MA, Padovani CR, et al. Follow-up study of morphology and cardiac    function in rats undergoing induction of supravalvular aortic stenosis. Arq    Bras Cardiol. 2003;81(6):569-75.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Follow-up study of morphology and cardiac function in rats undergoing induction of supravalvular aortic stenosis</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>569</fpage>
          <lpage>75</lpage>
          <issue>6</issue>
          <volume>81</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ribeiro</surname>
              <given-names>HB</given-names>
            </name>
            <name>
              <surname>Okoshi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Cicogna</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Bregagnollo</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Rodrigues</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Padovani</surname>
              <given-names>CR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Chalela WA, Moffa PJ. Teste ergom&#233;trico.    In: Negr&#227;o CE, Barreto AC. (eds). Cardiologia do exerc&#237;cio - do    atleta ao cardiopata. S&#227;o Paulo: Barueri; 2005. p. 92-126.</mixed-citation>
        <element-citation publication-type="book">
          <source>Cardiologia do exerc&#237;cio - do atleta ao cardiopata</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>92</fpage>
          <lpage>126</lpage>
          <person-group person-group-type="author">
            <name>
              <surname>Chalela</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Moffa</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Negr&#227;o</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Barreto</surname>
              <given-names>AC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Sullivan MJ, Hawthorne MH. Exercise intolerance    in patients with chronic heart failure. Prog Cardiovasc Dis. 1995;38(1):1-22.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Exercise intolerance in patients with chronic heart failure</article-title>
          <source>Prog Cardiovasc Dis</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>1</fpage>
          <lpage>22</lpage>
          <issue>1</issue>
          <volume>38</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sullivan</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Hawthorne</surname>
              <given-names>MH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Kitzman DW, Little WC, Brubaker PH, Anderson    RT, Hundley WG, Marburger CT, et al. Pathophysiological characterizationof isolated    diastolic heart failure in comparison to systolic heart failure. JAMA. 2002;288(17):2144-50.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Pathophysiological characterizationof isolated diastolic heart failure in comparison to systolic heart failure</article-title>
          <source>JAMA</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>2144</fpage>
          <lpage>50</lpage>
          <issue>17</issue>
          <volume>288</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kitzman</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Little</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Brubaker</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Hundley</surname>
              <given-names>WG</given-names>
            </name>
            <name>
              <surname>Marburger</surname>
              <given-names>CT</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. Kitzman DW. Exercise intolerance. Prog Cardiovasc    Dis. 2005;47(6):367-79.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Exercise intolerance</article-title>
          <source>Prog Cardiovasc Dis</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>367</fpage>
          <lpage>79</lpage>
          <issue>6</issue>
          <volume>47</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kitzman</surname>
              <given-names>DW</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. de Paiva SA, Zornoff LA, Okoshi MP, Okoshi    K, Matsubara LS, Matsubara BB, et al. Ventricular remodeling induced by retinoic    acid supplementation in adult rats. Am J Physiol Heart Circ Physiol. 2003;284(6):H2242-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Ventricular remodeling induced by retinoic acid supplementation in adult rats</article-title>
          <source>Am J Physiol Heart Circ Physiol</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>H2242</fpage>
          <lpage>6</lpage>
          <issue>6</issue>
          <volume>284</volume>
          <person-group person-group-type="author">
            <name>
              <surname>de Paiva</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Zornoff</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Okoshi</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Okoshi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Matsubara</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Matsubara</surname>
              <given-names>BB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Carvalho JF, Masuda MO, Pompeu FA. Method    for diagnosis and control of aerobic training in rats based on lactate threshold.    Comp Biochem Physiol A Mol Integr Physiol. 2005;140(4):409-13.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Method for diagnosis and control of aerobic training in rats based on lactate threshold</article-title>
          <source>Comp Biochem Physiol A Mol Integr Physiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>409</fpage>
          <lpage>13</lpage>
          <issue>4</issue>
          <volume>140</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Carvalho</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Masuda</surname>
              <given-names>MO</given-names>
            </name>
            <name>
              <surname>Pompeu</surname>
              <given-names>FA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Bech OM, Sorensen JD, Jensen MK, Diamant    B, Steiness E. Effects of long-term Coenzyme Q<sub>10</sub> and captopril treatment    on survival and functional capacity in rats with experimentally induced heart    infarction. J Pharmacol Exp Ther. 1990;255(1):346-50.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effects of long-term Coenzyme Q10 and captopril treatment on survival and functional capacity in rats with experimentally induced heart infarction</article-title>
          <source>J Pharmacol Exp Ther</source>
          <date>
            <year>1990</year>
          </date>
          <fpage>346</fpage>
          <lpage>50</lpage>
          <issue>1</issue>
          <volume>255</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bech</surname>
              <given-names>OM</given-names>
            </name>
            <name>
              <surname>Sorensen</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Diamant</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Steiness</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Svedahl K, MacIntosh BR. Anaerobic threshold:    the concept and methods of measurement. Can J Appl Physiol. 2003;28(2):299-323.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Anaerobic threshold: the concept and methods of measurement</article-title>
          <source>Can J Appl Physiol</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>299</fpage>
          <lpage>323</lpage>
          <issue>2</issue>
          <volume>28</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Svedahl</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>MacIntosh</surname>
              <given-names>BR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. Okoshi K, Ribeiro HB, Okoshi MP, Matsubara    BB, Gon&#231;alves G, Barros R, et al. Improved systolic ventricular function    with normal myocardial mechanics in compensated cardiac hypertrophy. Jpn Heart    J. 2004;45(4):647-56.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Improved systolic ventricular function with normal myocardial mechanics in compensated cardiac hypertrophy</article-title>
          <source>Jpn Heart J</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>647</fpage>
          <lpage>56</lpage>
          <issue>4</issue>
          <volume>45</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Okoshi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>HB</given-names>
            </name>
            <name>
              <surname>Okoshi</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Matsubara</surname>
              <given-names>BB</given-names>
            </name>
            <name>
              <surname>Gon&#231;alves</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Barros</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B21">
        <mixed-citation>21. Litwin SE, Raya TE, Anderson PG, Litwin CM,    Breezier R, Goldman S. Induction of myocardial hypertrophy following coronary    ligation in rats decreases left ventricular dilatation and improves systolic    function. Circulation. 1991;84(4):1819-27.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Induction of myocardial hypertrophy following coronary ligation in rats decreases left ventricular dilatation and improves systolic function</article-title>
          <source>Circulation</source>
          <date>
            <year>1991</year>
          </date>
          <fpage>1819</fpage>
          <lpage>27</lpage>
          <issue>4</issue>
          <volume>84</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Litwin</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Raya</surname>
              <given-names>TE</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Litwin</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Breezier</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Goldman</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22. Bregagnollo EA, Mestrinel MA, Okoshi K, Carvalho    FC, Bregagnollo IF, Padovani CR, et al. Relative role of left ventricular geometric    remodeling and of morphological and functional myocardial remodeling in the    transition from compensated hypertrophy to heart failure in rats with supravalvar    aortic stenosis. Arq Bras Cardiol. 2007;88(2):225-33.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Relative role of left ventricular geometric remodeling and of morphological and functional myocardial remodeling in the transition from compensated hypertrophy to heart failure in rats with supravalvar aortic stenosis</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>225</fpage>
          <lpage>33</lpage>
          <issue>2</issue>
          <volume>88</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bregagnollo</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Mestrinel</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Okoshi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>FC</given-names>
            </name>
            <name>
              <surname>Bregagnollo</surname>
              <given-names>IF</given-names>
            </name>
            <name>
              <surname>Padovani</surname>
              <given-names>CR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <mixed-citation>23. Boluyt MO, O'Neill L, Meredith AL, Bing OH,    Brooks WW, Conrad CH, et al. Alterations in cardiac gene expression during the    transition from stable hypertrophy to heart failure: marked upregulation of    genes encoding extracellular matrix components. Circ Res. 1994;75(1):23-32.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure: marked upregulation of genes encoding extracellular matrix components</article-title>
          <source>Circ Res</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>23</fpage>
          <lpage>32</lpage>
          <issue>1</issue>
          <volume>75</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Boluyt</surname>
              <given-names>MO</given-names>
            </name>
            <name>
              <surname>O'Neill</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Meredith</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Bing</surname>
              <given-names>OH</given-names>
            </name>
            <name>
              <surname>Brooks</surname>
              <given-names>WW</given-names>
            </name>
            <name>
              <surname>Conrad</surname>
              <given-names>CH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B24">
        <mixed-citation>24. Boluyt MO, Robinson KG, Meredith AL, Sen    S, Lakatta EG, Crow MT, et al. Heart failure after long-term supravalvar aortic    constriction in rats. Am J Hypertens. 2005;18(2 Pt 1):202-12.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Heart failure after long-term supravalvar aortic constriction in rats</article-title>
          <source>Am J Hypertens</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>202</fpage>
          <lpage>12</lpage>
          <issue>2 Pt 1</issue>
          <volume>18</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Boluyt</surname>
              <given-names>MO</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>KG</given-names>
            </name>
            <name>
              <surname>Meredith</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Sen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lakatta</surname>
              <given-names>EG</given-names>
            </name>
            <name>
              <surname>Crow</surname>
              <given-names>MT</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <mixed-citation>25. Pritchett AM, Jacobsen SJ, Mahoney DW, Rodeheffer    RJ, Bailey KR, Redfield MM. Left atrial volume as an index of left atrial size:    a population-based study. J Am Coll Cardiol. 2003;41(6):1036-43.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Left atrial volume as an index of left atrial size: a population-based study</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>1036</fpage>
          <lpage>43</lpage>
          <issue>6</issue>
          <volume>41</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Pritchett</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Jacobsen</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Mahoney</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Rodeheffer</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Bailey</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Redfield</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B26">
        <mixed-citation>26. Bayat H, Swaney JS, Ander AN, Dalton N, Kennedy    BP, Hammond HK, et al. Progressive heart failure after myocardial infarction    in mice. Basic Res Cardiol. 2002;97(3):206-13.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Progressive heart failure after myocardial infarction in mice</article-title>
          <source>Basic Res Cardiol</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>206</fpage>
          <lpage>13</lpage>
          <issue>3</issue>
          <volume>97</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bayat</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Swaney</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Ander</surname>
              <given-names>AN</given-names>
            </name>
            <name>
              <surname>Dalton</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kennedy</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Hammond</surname>
              <given-names>HK</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B27">
        <mixed-citation>27. Morris GS, Fitzsimons DP, Baldwin KM, Barbard    RJ. Exercise capacity of rats remains unaffected by a chronic pressure overload.    Cardiovasc Res. 1993;27(7):1346-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Exercise capacity of rats remains unaffected by a chronic pressure overload</article-title>
          <source>Cardiovasc Res</source>
          <date>
            <year>1993</year>
          </date>
          <fpage>1346</fpage>
          <lpage>9</lpage>
          <issue>7</issue>
          <volume>27</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Morris</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Fitzsimons</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Baldwin</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Barbard</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B28">
        <mixed-citation>28. Contarteze RV, Manchado Fde B, Gobatto CA,    De Mello MA. Stress biomarkers in rats submitted to swimming and treadmill running    exercises. Comp Biochem Physiol A Mol Integr Physiol. 2008;151(3):415-22.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Stress biomarkers in rats submitted to swimming and treadmill running exercises</article-title>
          <source>Comp Biochem Physiol A Mol Integr Physiol</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>415</fpage>
          <lpage>22</lpage>
          <issue>3</issue>
          <volume>151</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Contarteze</surname>
              <given-names>RV</given-names>
            </name>
            <name>
              <surname>Manchado Fde</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Gobatto</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>De Mello</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B29">
        <mixed-citation>29. Guazzi M, Brenner DA, Apstein CS, Saupe KW.    Exercise intolerance in rats with hypertensive heart disease is associated with    impaired diastolic relaxation. Hypertension. 2001;37(2):204-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Exercise intolerance in rats with hypertensive heart disease is associated with impaired diastolic relaxation</article-title>
          <source>Hypertension</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>204</fpage>
          <lpage>8</lpage>
          <issue>2</issue>
          <volume>37</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Guazzi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Brenner</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Apstein</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Saupe</surname>
              <given-names>KW</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B30">
        <mixed-citation>30. Das P, Rimington H, Chambers J. Exercise    testing to stratify risk in aortic stenosis. Eur Heart J. 2005;26(13):1309-13.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Exercise testing to stratify risk in aortic stenosis</article-title>
          <source>Eur Heart J</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>1309</fpage>
          <lpage>13</lpage>
          <issue>13</issue>
          <volume>26</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Das</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Rimington</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Chambers</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B31">
        <mixed-citation>31. Ferreira JC, Rolim NP, Bartholomeu JB, Gobatto    CA, Kokubun E, Brum PC. Maximal lactate steady state in running mice: effect    of exercise training. Clin Exp Pharmacol Physiol. 2007;34(8):760-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Maximal lactate steady state in running mice: effect of exercise training</article-title>
          <source>Clin Exp Pharmacol Physiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>760</fpage>
          <lpage>5</lpage>
          <issue>8</issue>
          <volume>34</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ferreira</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Rolim</surname>
              <given-names>NP</given-names>
            </name>
            <name>
              <surname>Bartholomeu</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Gobatto</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Kokubun</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Brum</surname>
              <given-names>PC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Exercise tolerance in rats with aortic stenosis and ventricular diastolic and/or systolic dysfunction</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: Physical stress tolerance (ST) is a measurement of cardiorespiratory fitness. Aerobic capacity is reduced in heart failure (HF) although there is no data available on this parameter in animals with ventricular dysfunction and no signs of HF. OBJECTIVE: Evaluate ST in rats with ventricular diastolic dysfunction isolated or associated with systolic dysfunction induced by ascending aortic stenosis (AoS). METHODS: Young male Wistar rats (20-30 days old), divided in: control group (CG, n=11) and AoSG group, (n=12). Animals were assessed at 6 and 18 weeks after AoS surgery. Treadmill exercise test was until exhaustion and evaluated treadmill speed and lactate concentration [LAC] at lactate threshold, treadmill speed and [LAC] at exhaustion, and total testing time. RESULTS: Echocardiography data revealed remodeling of the left atrium and left ventricular concentric hypertrophy at 6 and 18 weeks. Endocardial fractional shortening was greater in AoSG than CG at 6 and 18 weeks. Midwall fractional shortening was greater in AoSG than in CG only 6 week. Cardiac index was similar in CG and AoSG at 6 and 18 weeks and decreased between from 6 to 18 weeks in both groups. The E wave to A wave ratio was greater in CG than in AoSG at both periods and did not change in both groups between week 6 and 18. Treadmill stress testing parameters were similar in both groups at 6 or 18 weeks. CONCLUSION: Although AoS promotes isolated diastolic dysfunction or associated with systolic dysfunction at 6 or 18 weeks, it is not sufficient to modify physical stress tolerance.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Mice</kwd>
        <kwd>Exercise</kwd>
        <kwd>Aortic Valve Stenosis</kwd>
        <kwd>Ventricular Dysfunction</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <fn id="top-body2">
          <label>
            <bold>Exercise tolerance in rats with aortic stenosis and ventricular diastolic and/or systolic dysfunction</bold>
          </label>
          <p>
            <bold>Olga Castro Mendes<sup>I, II</sup>; Mario Mateus Sugizaki<sup>I, III</sup>; Dijon Salom&#233; Campos<sup>I</sup>; Ricardo Luiz Damatto<sup>I</sup>; Andr&#233; Soares Leopoldo<sup>I, IV</sup>; Ana Paula Lima-Leopoldo<sup>I, IV</sup>; Vilmar Baldissera<sup>V</sup>; Carlos Roberto Padovani<sup>I</sup>; Katashi Okoshi<sup>I</sup>; Antonio Carlos Cicogna<sup>I</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Departamento de Cl&#237;nica M&#233;dica - Faculdade de Medicina - Universidade Estadual Paulista (UNESP) "J&#250;lio de Mesquita Filho", Botucatu, SP, Brazil</p>
      <p><sup>II</sup>Faculdades Integradas de Bauru, Bauru, SP, Brasil </p>
      <p><sup>III</sup>Instituto de Ci&#234;ncias da Sa&#250;de - Universidade Federal de Mato Grosso (UFMT), Sinop, MT, Brazil</p>
      <p><sup>IV</sup>Departamento de Desportos - Centro de Educa&#231;&#227;o F&#237;sica e Desportos - Universidade Federal do Esp&#237;rito Santo (UFES), Vit&#243;ria, ES, Brazil</p>
      <p><sup>V</sup>Laborat&#243;rio de Fisiologia do Exerc&#237;cio - Universidade Federal de S&#227;o Carlos (UFSCar), S&#227;o Carlos, SP, Brazil</p>
      <p>Mailing Address</p>
      <p>
        <bold>ABSTRACT</bold>
      </p>
      <p><bold>BACKGROUND:</bold> Physical stress tolerance (ST) is a measurement of cardiorespiratory fitness. Aerobic capacity is reduced in heart failure (HF) although there is no data available on this parameter in animals with ventricular dysfunction and no signs of HF.</p>
      <p><bold>OBJECTIVE:</bold> Evaluate ST in rats with ventricular diastolic dysfunction isolated or associated with systolic dysfunction induced by ascending aortic stenosis (AoS).</p>
      <p><bold>METHODS:</bold> Young male Wistar rats (20-30 days old), divided in: control group (CG, n=11) and AoSG group, (n=12). Animals were assessed at 6 and 18 weeks after AoS surgery. Treadmill exercise test was until exhaustion and evaluated treadmill speed and lactate concentration [LAC] at lactate threshold, treadmill speed and [LAC] at exhaustion, and total testing time.</p>
      <p><bold>RESULTS:</bold> Echocardiography data revealed remodeling of the left atrium and left ventricular concentric hypertrophy at 6 and 18 weeks. Endocardial fractional shortening was greater in AoSG than CG at 6 and 18 weeks. Midwall fractional shortening was greater in AoSG than in CG only 6 week. Cardiac index was similar in CG and AoSG at 6 and 18 weeks and decreased between from 6 to 18 weeks in both groups. The E wave to A wave ratio was greater in CG than in AoSG at both periods and did not change in both groups between week 6 and 18. Treadmill stress testing parameters were similar in both groups at 6 or 18 weeks.</p>
      <p><bold>CONCLUSION:</bold> Although AoS promotes isolated diastolic dysfunction or associated with systolic dysfunction at 6 or 18 weeks, it is not sufficient to modify physical stress tolerance. (Arq Bras Cardiol. 2012; [online].ahead print, PP.0-0)</p>
      <p><bold>Keywords:</bold> Mice; Exercise; Aortic Valve Stenosis; Ventricular Dysfunction.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>The term cardiac remodeling (CR) has been widely used and can be defined as a modification in genome expression resulting in molecular, cellular and interstitial changes that clinically manifest as changes in size, shape and function of the heart following aggression<sup>1</sup>.</p>
      <p>CR is an important adaptive mechanism to chronic hemodynamic load that allows the heart to maintain its basic functions in response to increased load<sup>2</sup>, but it is also a considerable risk factor for ventricular dysfunction and heart failure<sup>3</sup>.</p>
      <p>A variety of experimental models have been proposed to investigate pressure overload-induced CR<sup>4-6</sup>. More recently, the model of ascending aortic stenosis (AoS) has been used to promote the gradual development of left ventricular hypertrophy in rats<sup>7-9</sup>. In this model, animals develop cardiac remodeling that is associated, in the short term, with diastolic dysfunction and improved systolic function followed by depressed systolic performance and heart failure<sup>10,11</sup>.</p>
      <p>The physical stress test (ST), one of the most commonly used noninvasive methods for the evaluation of cardiovascular disease, can detect heart function abnormalities not observable at rest<sup>12,13</sup>. Tolerance to ST, a normative measurement of cardiorespiratory fitness and aerobic capacity, is the ability to perform dynamic activities during physical stress. This ability is commonly reduced in patients and animals with heart failure (HF)<sup>14,15</sup>. However, information on patients and animals with ventricular dysfunction and no signs of HF was not found in the literature.</p>
      <p>The purpose of this study was to test the hypothesis that tolerance to physical stress is impaired in the presence of ventricular diastolic dysfunction isolated or associated with systolic dysfunction and no heart failure induced by aortic stenosis.</p>
      <p>
        <bold>Methods</bold>
      </p>
      <p>All experiments and procedures were performed in agreement with <italic>Guide for the Care and Use of Laboratory Animals </italic>published by the National Research Council (1996) and were approved by the Animal Ethics Committee of the Botucatu Medical School, UNESP - Universidade Estadual J&#250;lio Mesquita Filho on 10/19/2005 (protocol number 506/2005).</p>
      <p>
        <bold>Animal</bold>
      </p>
      <p>Twenty-three young male <italic>Wistar </italic>rats were randomly distributed in two groups: control (CG, n=11) and ascending aortic stenosis (AoSG, n=12). In AoSG, aortic stenosis was induced by placing a silver band on the aorta. CG underwent the same surgery without band placement. All animals were housed in individual cages in a room maintained at 23&#176;C on a 12:12-h light-dark cycle and fed standard Purina<sup>&#174; </sup>rat chow and water <italic>ad libitum</italic>.</p>
      <p>
        <bold>Ascending aortic stenosis induction </bold>
      </p>
      <p>Cardiac remodeling was induced by AoS according to the method used by several authors<sup>5,7,9</sup>. The animals, weighing 70-90 g, 20-30 days old, underwent median thoracotomy under anesthesia with intraperitoneal ketamine hydrochloride (60 mg/kg) and xylidine hydrochloride (10 mg/kg). The ascending aorta was dissected and a 0.6-mm internal diameter silver band was placed at approximately 3 mm of the aortic root. CG animals underwent the same surgery, but without band placement.</p>
      <p>According to previous studies, animals start to develop ventricular diastolic dysfunction isolated or associated with systolic dysfunction at 6 and 18 weeks after surgery, respectively<sup>5,7,9</sup>. Thus, all animals were assessed at these time points: 6 weeks (diastolic dysfunction) and 18 weeks (diastolic dysfunction associated with systolic).</p>
      <p>
        <bold>Echocardiography assessment</bold>
      </p>
      <p>LV diastolic and systolic functions as well as heart structure were assessed by ECHO according to the method used in our laboratory<sup>7,16</sup>. The animals were anesthetized with intraperitoneal ketamine hydrochloride (50 mg/kg) and xylidine hydrochloride (1 mg/kg) for examination with a M-Mode echocardiograph (<italic>Philips</italic><sup>&#174;</sup><italic>, </italic>model HDI 5000) equipped with a 12-MHz electronic transducer to measure the left atrium diameter (LA) and the following left ventricular parameters: diastolic and systolic diameter (LVDD and LVSD, respectively), diastolic and systolic posterior wall thickness (LVDWT and LVSWT, respectively), diastolic and systolic interventricular septal thickness (IVSDT and IVSST), and left ventricle mass (LV MASS). The left ventricular mass index (LVMI) was determined by normalizing LV mass for body weight (BW). LV wall relative thickness (LVWRT) was estimated dividing LVDWT by LVDD.</p>
      <p>The LV systolic function was determined by the percent of endocardial shortening (&#916;D endo) and the midwall fractional shortening (&#916;D mid), and cardiac index (CI). The &#916;D mid was calculated using the formula ({[(LVDD + &#189; PWDT + &#189; IVSDT) - (LVSD + &#189; PWST + &#189; IVSST)]/(LVDD + &#189; PWDT + &#189; IVSDT )}). The &#916;D endo was calculated by the formula ([(LVDD - LVSD)/LV DD x 100].</p>
      <p>The diastolic function was assessed by E-waves and A, ratio between E-waves and A-wave (E/A).</p>
      <p>
        <bold>Assessment of physical stress tolerance</bold>
      </p>
      <p>
        <bold>Physical stress testing</bold>
      </p>
      <p>Stress testing was performed using a rodent treadmill constructed by the Technological Center of Clinical Engineering - Universidade Estadual J&#250;lio Mesquita Filho UNESP/Botucatu, S&#227;o Paulo, Brazil. The protocol used for multistage interval testing was adapted from that previously described by Carvalho et al<sup>17</sup>. Each animal was tested individually. The test consisted of an initial 5-min warm up at 5m/min. After 1 min of passive recuperation, the animal was submitted to interval exercise at a speed of 6m/min followed by 3m/min increases in speed every 3 minutes until exhaustion. Exhaustion was determined when the animal refused to run even after sound stimulation or was unable to coordinate steps. After each load increase, the animal was manually taken out of the treadmill for 1 min for blood collection<sup>18</sup>.</p>
      <p>
        <bold>Experimental Protocol </bold>
      </p>
      <p>A schematic representation of the test protocol is shown in <xref ref-type="fig" rid="en_aop012fig1-body2">Figure 1</xref>. All rats underwent a period of adaptation to become familiarized with the experiment protocol by daily walking 5 minutes at 5 m/min for one week before testing. Physical stress testing was performed 6 and 18 weeks after surgery in CG and AoSG, that is, by the diastolic dysfunction isolated or associated with systolic dysfunction, respectively.</p>
      <p content-type="asset">
        <fig id="en_aop012fig1-body2">
          <graphic xlink:href="1678-4170-abc-100-01-0044-00112-gf01-en.jpg"/></fig>
      </p>
      <p>
        <bold>Parameters assessed </bold>
      </p>
      <p>
        <bold>Treadmill speed (SLT, m/min) and lactate concentration ([LAC]<sub>LT, </sub>mmol/L) at lactate threshold</bold>
      </p>
      <p>For the assessment of SLT and [LAC]<sub>LT</sub>, it was necessary to determine lactate threshold (LT), defined as the exercise intensity at which lactate concentration starts to substantially increase in the bloodstream during incremental exercise<sup>19</sup>. Blood samples (25 &#181;l) were drawn from the tail of animals at rest and after every load increase. Collection was carried out using 25x75x1mm glass microscope slides (<italic>Sigma Chemical Company</italic><sup>&#174;</sup> - USA, model <italic>Techware</italic> S 8902) and 20-200 &#181;l digital micropipettes (<italic>Nichiryo Co</italic>.<sup>&#174;</sup> - Japan, model <italic>Nichipet</italic> NPX 200) with disposable tips that were changed after each collection. The blood collected was immediately stored in 1.5-ml <italic>Eppendorf </italic>tubes with lid containing 50 &#181;l of 1% fluoride, anticoagulant and enolase enzyme inhibitor to suppress glycolytic activity. Blood samples were refrigerated during collection and then kept in a freezer until use. Lactate concentration was determined by the electroenzymatic method using a lactimeter (<italic>Yellow Springs Instruments</italic><sup>&#174;</sup>, 1500 <italic>Sport -</italic> USA) owned by the Exercise Physiology Laboratory of the Department of Physiological Sciences - Universidade Federal S&#227;o Carlos, S&#227;o Paulo, Brazil. The device was calibrated according to the instructions of the manufacturer. Lactate concentrations were plotted against stage speed. LT was considered as the point where lactate levels started to rise as a function of speed as detected by visual inspection. The speed and lactate concentration found at this point were considered as speed and lactate concentration at lactate threshold (SLT and [LAC]<sub>LT, </sub>respectively). The graphs were analyzed by two experienced investigators with an inter-observer agreement of 96 %. When disagreement regarding LT occurred, the mean of the values indicated by each observer was used. The graph plotting results for one of the animals are shown in <xref ref-type="fig" rid="en_aop012fig2-body2">Figure 2</xref>.</p>
      <p content-type="asset">
        <fig id="en_aop012fig2-body2">
          <graphic xlink:href="1678-4170-abc-100-01-0044-00112-gf02-en.jpg"/></fig>
      </p>
      <p><bold>Treadmill speed (SEx, m/min) and lactate concentration ([LAC]<sub>EX</sub>, mmol/L) at exhaustion </bold>These parameters were determined as described above, but at exhaustion.</p>
      <p>
        <bold> Total testing time (TTT, sec)</bold>
      </p>
      <p>TTT was the sum of all stage times up to exhaustion. Intervals between stages were not taken into consideration.</p>
      <p>
        <bold>Body and heart morphological characteristics </bold>
      </p>
      <p>By the end of the experiment, the animals were anesthetized with intraperitoneal sodium pentobarbital (50 mg/kg) and decapitated. The following variables were assessed: final body weight (BW), LV weight, RV weight, atrial (left + right) weight (A), LV/BW, RV/BW, A/BW. Fragments of liver (LIVER<sub>w/d</sub>) and lung (LUNG<sub>w/d</sub>) were weighed before and after they were placed in an oven at 60&#176;C for 48 h to obtain the wet-to-dry ratio.</p>
      <p>
        <bold>Statistical Analysis</bold>
      </p>
      <p>Results are reported as position and variability measurements according to data distribution. Morphological parameters were analyzed using the Student's t-test, when the variable has shown adherence to the normal probability distribution, and using the Mann-Whitney test, when this characteristic was absent. Comparisons between groups were performed using two-way repeated measures ANOVA with one-factor repetition followed by Bonferroni's multiple comparison procedure. For non-parametric parameters, Anova on ranks and Friedman test was used. Significance level for all tests was set at 5% (p&lt;0.05). Statistical calculations were performed using <italic>SigmaStat </italic>3.5 <italic>for Windows version</italic> (<italic>Copyright</italic><sup>&#169;</sup> 2006, <italic>Systat Software Inc</italic>.).</p>
      <p>
        <bold>Results</bold>
      </p>
      <p><xref ref-type="table" rid="en_aop012tab1-body2">Table 1</xref> summarizes morphological data. Body weight was similar in control group (CG) e ascending aortic stenosis group (AoSG). The LV/body weight, RV/body weight and A/body weight were increased in AoSG in relation of CG. There was no difference in LIVER<sub>w/d</sub> and LUNG<sub>w/d</sub> fragments.</p>
      <p content-type="asset">
        <table-wrap id="en_aop012tab1-body2">
          <graphic xlink:href="1678-4170-abc-100-01-0044-00112-gt01-en.jpg"/></table-wrap>
      </p>
      <p><xref ref-type="table" rid="en_aop012tab2-body2">Table 2</xref> shows serial echocardiographic data of structural and functional parameters at 6 and 18 weeks in CG and AoSG. Left ventricular mass index decreased between week 6 and week 18 in CG and remained unchanged in AoSG; this parameter was higher in AoSG than CG at 6 and 18 weeks. Left ventricular wall relative thickness did not change in CG, but increased between week 6 and week 18 in AoSG; this variable was higher in AoSG than in CG at 6 and 18 weeks. LA/BW decreased in both groups at week 18 when compared to week 6; it was higher in AoSG than in CG at both evaluated times. Endocardial (&#916;D endo) and midwall (&#916;D mid) fractional shortening did not change with time in CG, but both decreased between 6 and 18 weeks in the AoSG; &#916;D endo was higher in AoSG than in CG at 6 and 18 weeks; &#916;D mid was higher in AoSG than in CG at week 6 and similar in both groups at week 18. Cardiac index decreased in both groups between 6 and 18 weeks; it was similar between both groups in the two evaluated times. E/A was similar in both groups between weeks 6 and 18; however, it was higher in CG than in AoSG in both moments.</p>
      <p content-type="asset">
        <table-wrap id="en_aop012tab2-body2">
          <graphic xlink:href="1678-4170-abc-100-01-0044-00112-gt02-en.jpg"/></table-wrap>
      </p>
      <p><xref ref-type="table" rid="en_aop012tab3-body2">Table 3</xref> shows the results of physical stress tolerance assessment. There was no significant difference in speed at exhaustion, total testing time, speed at lactate threshold, lactate concentrations at SLT and at SEx between 6 and 18 weeks in both groups. These parameters were similar between CG and AoSG in both moments.</p>
      <p content-type="asset">
        <table-wrap id="en_aop012tab3-body2">
          <graphic xlink:href="1678-4170-abc-100-01-0044-00112-gt03-en.jpg"/></table-wrap>
      </p>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>The aortic stenosis employed in this study promoted early left atrium and ventricular hypertrophy, which persisted up to the end of the experiment. It was observed by atrial and ventricular mass at morphologic and echocardiography analysis. The increase of left ventricle wall relative thickness in stenosis group indicates concentric hypertrophy. The data are in agreement with previous studies that showed cardiac remodeling in this experimental model<sup>5,9,11,20</sup>. Remodeling of the left chamber is an adaptive response to ventricular pressure rise; the increase in wall thickness and cavity volume decrease normalize parietal stress and, in consequence, LV function<sup>1,21</sup>. No clinical or morphological signs of heart failure, i.e. tachypnea associated with edema, ascites, pleuropericardial effusion, LA thrombus or RV hypertrophy were observed. The isolated finding of an increase in RV/BW ratio does not indicate that AoSG rats developed heart failure; this was confirmed by the fact that LIVER<sub>w/d</sub> and LUNG<sub>w/d</sub> were similar in control and AoS groups.</p>
      <p>LV systolic function, as assessed by &#916;D endo and &#916;D mid, was increased in AoSG when compared with CG at week 6, and deteriorated during remodeling in the AoSG (<xref ref-type="table" rid="en_aop012tab2-body2">Table 2</xref>). The &#916;D endo observed at week 6 was similar to that reported by Bregagnollo et al<sup>7,22</sup>, Ribeiro et al<sup>11</sup> and Litwin et al<sup>9</sup> who found an improved systolic function at this time. Furthermore, these authors also observed worsening after 18 or 21 weeks. The improved systolic function seen in AoSG, in comparison with CG at week 6 might be related to the development of concentric hypertrophy, wall systolic tension normalization, and maintenance of myocardial fiber oxygen consumption within its physiological range<sup>9</sup>. The progressive loss of systolic function may be related with adverse remodeling of ventricular geometry, changes in myocardial composition, progressive contractility impairment or with all those factors combined<sup>22-24</sup>.</p>
      <p>Differently from systolic function, diastolic performance deteriorated early in AoSG in comparison with CG. At week 6, there was a reduction in E/A ratio which remained observable at week 18. AoSG E/A ratio, which was smaller than in CG, suggests the presence of diastolic dysfunction. Our results differ from author<sup>9</sup> that observed no changes in E/A ratio 6 weeks after AoS induction in rats and investigators who found an increase in E/A 12, 18 or 21 weeks after AoS induction<sup>7,9,22</sup>. Conflicting results may occur due to the different levels of left ventricular hypertrophy or technical difficulties in obtaining images adequate for the analysis of the Doppler effect; the high heart rate in rats fuse E and A waves making it difficult to measure diastolic function<sup>25</sup>. Despite the inconsistent results found assessing diastolic function using E/A 6 weeks, an increased LA diameter observed in this study indicates LV diastolic dysfunction, since an improved systolic function was observed in the AoS group in comparison with controls. During ventricular diastole, LA is directly exposed to intraventricular pressures through the mitral valve. Eventual rises in ventricular diastolic pressure increase atrial pressure and thereby chamber remodeling. Experimental studies of AoS have associated myocardial stiffness with an increase in collagen fibers and changes in the proteins involved in intracellular calcium reuptake, particularly the sarcoplasmic reticulum calcium pump<sup>24</sup>. Thus, the diastolic function depression observed 6 and 18 weeks after AoS may be related with changes in elastic properties and disturbances in calcium handling.</p>
      <p>While the echocardiographic data showed functional and structural changes at weeks 6 and 18, stress tolerance test did not detect change in functional capacity in both groups. In our knowledge, it's the first research that evaluated exercise physical tolerance in rat with ascending aortic stenosis. The TTT was the only parameter to show a strong tendency toward decrease in animal with AoS (0.05&lt;p&lt;0.10). The similar stress response may be due to: 1) an inadequate protocol; 2) parameters insensitive to detect changes in functional capacity; and 3) ventricular dysfunction level. With regard to the first item, the physical stress testing used can be considered adequate for the following reasons: i) similar methods have been used in other experimental studies<sup>17,26</sup>; ii) it allowed submitting the animals to an individualized physical stress program; iii) the gradual increase of load interrupted the linear pattern of the lactate concentration curve and allowed determining LT; iiii) no deaths occurred during testing or immediately afterward, indicating that, despite being a maximal test, it can be used in the experimental AoS model. The parameters used were considered appropriate because: i) SLT and/or SEx have been successfully used in several experimental works in normal rats<sup>17,27,28</sup>, in rats with abdominal aortic stenosis or myocardial infarction<sup>18,27</sup>; ii) TTT has also been employed to assess functional capacity in infarcted and hypertensive animals<sup>26,29</sup>. In asymptomatic AoS patients, it has been considered to be a good predictor of the onset of heart failure signs<sup>30</sup>; iii) [LAC]<sub>LT</sub> and [LAC]<sub>EX</sub> have been used in experimental studies in humans as a marker of physical training intensity<sup>28</sup>. In relation to item 3, the literature shows that stress testing has detected functional capacity reduction in animals with ventricular diastolic dysfunction induced by arterial hypertension<sup>29</sup> or, more commonly, with heart failure induced by myocardial infarction<sup>26</sup>. Moreover, the test is reported to be negative in rats with abdominal aortic stenosis and compensated ventricular hypertrophy<sup>27</sup>, and in a rat model of hyperadrenalinemia induced by adrenalin tablet implantations. In this study, no signs of heart failure were observed, even though diastolic and systolic performances were depressed in AoSG during remodeling. Given that the literature shows that stress testing is significantly positive in animals with heart failure<sup>14,15</sup>, the absence of changes observed here may be related to the level of ventricular dysfunction, which was probably moderate. The similar data of cardiac index indicates peripheral blood flow perfusion equivalent between groups. Another explanation about absence of difference between groups can be related of speed exhaustion of control rats. Physical stress test protocol showed small values of speed at exhaustion (15 m/min) and speed at lactate threshold (9.0m/min) in control rats. In according to literature it would be expected higher values of these parameters. Ferreira et al<sup>31</sup> observed speed at exhaustion of 28 m/min and speed at lactate threshold of 15 m/min in untrained mice. Carvalho et al<sup>17</sup> shown speed at exhaustion of 19.5 m/min and speed at lactate threshold of 14.9 m/min in untrained rats. Despite of controversy data, the lactate concentration at exhaustion observed by us were similar at 18 m/min of speed in the Ferreira et al<sup>31</sup> study and in the speed of exhaustion (19.5 m/min) observed by Carvalho et al<sup>17</sup>. Therefore, it means that our rats attained maximum or near of maximum effort during exercise testing.</p>
      <p>The mechanisms responsible for the reduction in exercise capacity have not been completely elucidated. Some of the possible factors include inadequate flow to skeletal muscle secondary to systolic and/or diastolic dysfunction and changes in the metabolism of the peripheral musculature<sup>29</sup>. Since the response to physical stress remained unchanged during interval testing, the factors mentioned above either were absent or of insufficient magnitude in the rats with AoS assessed in this study.</p>
      <p>Some limitations about this research should be stated: 1) maximal physical exercise testing in rats with ventricular hypertrophy can be dangerous due to death risk; so our rats can perform sub maximal effort during test; 2) lacking of functional parameters that estimate exercise intensity during physical testing (i.e. heart rate, arterial pressure, oxygen consumption); 3) lacking literature data about time, speed running, lactate in similar experimental conditions.</p>
      <p>In conclusion, no changes in physical stress tolerance were observed in the presence of diastolic dysfunction isolated or associated with systolic dysfunction. The level of left ventricular dysfunction seems to be the major determinant on the results of this study. Further studies including animals with greater ventricular dysfunction or heart failure as well as the analysis of the mechanisms that might alter the cardiac remodeling/stress tolerance relationship are necessary.</p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>There were no external funding sources for this study.</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This article is part of the master thesis submitted by Olga de Castro Mendes da Silva, from Faculdade de Medicina da Universidade Estadual Paulista J&#250;lio de Mesquita Filho.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
</article>
